Literature DB >> 25942104

Glucocorticosteroids do not impact directly growth rate and biomass of Rhizopus arrhizus (syn. R. oryzae) in vitro.

A P Bellanger1, Y D Minetos, N Albert, F Shirazi, T J Walsh, D P Kontoyiannis.   

Abstract

Glucocorticoid (GC) use is a common risk factor for invasive fungal infections. This is attributed to the complex dysregulation of immunity caused by GCs. However, studies have demonstrated increased growth with GC exposure for some molds, such as Aspergillus fumigatus and Exserohilum rostratum. No such data exist for Mucorales. Therefore, we investigated the influence of GC exposure on the growth of Rhizopus arrhizus (syn. R. oryzae) in different culture media and in different atmospheres. We measured continuous spore growth using spectrophotometry and biomass variations using XTT assay. We did not observe enhanced growth or biomass variation with any of the GCs regardless of the medium or conditions. These results support the existence of fungus-specific differences in the effect of GCs on fungal biology.

Entities:  

Keywords:  Rhizopus oryzae; biomass; corticosteroid

Mesh:

Substances:

Year:  2015        PMID: 25942104      PMCID: PMC4601165          DOI: 10.1080/21505594.2015.1039762

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  9 in total

1.  Relationship between metabolism and biomass of medically important zygomycetes.

Authors:  Charalampos Antachopoulos; Joseph Meletiadis; Emmanuel Roilides; Tin Sein; Deanna A Sutton; Brian L Wickes; Michael G Rinaldi; William G Merz; Yvonne R Shea; Thomas J Walsh
Journal:  Med Mycol       Date:  2006-08       Impact factor: 4.076

2.  Increased culture recovery of Zygomycetes under physiologic temperature conditions.

Authors:  Dimitrios P Kontoyiannis; Georgios Chamilos; Saad A Hassan; Russell E Lewis; Nathaniel D Albert; Jeffrey J Tarrand
Journal:  Am J Clin Pathol       Date:  2007-02       Impact factor: 2.493

3.  Species boundaries and nomenclature of Rhizopus arrhizus (syn. R. oryzae).

Authors:  Somayeh Dolatabadi; G Sybren de Hoog; Jacques F Meis; Grit Walther
Journal:  Mycoses       Date:  2014-09-30       Impact factor: 4.377

Review 4.  Host cell invasion in mucormycosis: role of iron.

Authors:  Ashraf S Ibrahim
Journal:  Curr Opin Microbiol       Date:  2011-07-30       Impact factor: 7.934

5.  The involvement of cAMP in the growth inhibition of filamentous fungus Rhizopus nigricans by steroids.

Authors:  Natasa Jeraj; Helena Lenasi; Katja Breskvar
Journal:  FEMS Microbiol Lett       Date:  2005-01-01       Impact factor: 2.742

Review 6.  Glucocorticoids and invasive fungal infections.

Authors:  Michail S Lionakis; Dimitrios P Kontoyiannis
Journal:  Lancet       Date:  2003-11-29       Impact factor: 79.321

7.  Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis.

Authors:  T T Ng; G D Robson; D W Denning
Journal:  Microbiology (Reading)       Date:  1994-09       Impact factor: 2.777

8.  Methylprednisolone enhances the growth of Exserohilum rostratum in vitro, attenuates spontaneous apoptosis, and increases mortality rates in immunocompetent Drosophila flies.

Authors:  Dimitrios Farmakiotis; Fazal Shirazi; Yanan Zhao; Peguy J Saad; Nathaniel D Albert; Emmanuel Roilides; Thomas J Walsh; David S Perlin; Dimitrios P Kontoyiannis
Journal:  J Infect Dis       Date:  2014-05-15       Impact factor: 5.226

9.  Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency.

Authors:  A H Thomson; M C Devers; A M Wallace; D Grant; K Campbell; M Freel; J M C Connell
Journal:  Clin Endocrinol (Oxf)       Date:  2007-04-15       Impact factor: 3.478

  9 in total
  1 in total

1.  Statin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae.

Authors:  Anne-Pauline Bellanger; Alexander M Tatara; Fazal Shirazi; Teclegiorgis Gebremariam; Nathaniel D Albert; Russell E Lewis; Ashraf S Ibrahim; Dimitrios P Kontoyiannis
Journal:  J Infect Dis       Date:  2016-03-16       Impact factor: 5.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.